Karyopharm Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2015
Total Assets: $215.4M
Liabilities Breakdown FY2015
Total Liabilities: $17.1M
Asset Breakdown
Total Assets: $215.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $58.4M | 27.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.5M | 1.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $153.6M | 71.3% |
Liabilities Breakdown
Total Liabilities: $17.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.8M | 22.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $13.3M | 77.7% |